Natalie McNamee
Investitore di Private Equity presso Tarnagulla Ventures Pty Ltd.
Profilo
Natalie has been a Director of Tarnagulla Ventures Pty Ltd since 2015.
She had led the investment diligence into most of the portfolio companies since then, including Lubris BioPharma, a company which has since successfully licensed their lead indication to Novartis.
Prior to returning to Australia, Natalie worked for Tocagen Inc, a gene therapy company, based in San Diego, in their business development team whilst finishing her Masters.
She then worked as a bioengineer at the then-newly formed Quanticel Pharmaceuticals, a cancer stem cell focused drug developer.
Quanticel was acquired by Celgene for $485M in 2015.
Natalie received her Masters in Bioengineering at UC San Diego and a dual Bachelor of Finance and Mechanical Engineering from Melbourne University.
Posizioni attive di Natalie McNamee
| Società | Posizione | Inizio |
|---|---|---|
Tarnagulla Ventures Pty Ltd.
 Tarnagulla Ventures Pty Ltd. Investment ManagersFinance Tarnagulla Ventures Pty Ltd (Tarnagulla Ventures) is a venture capital firm founded in 2015. The firm is headquartered in Melbourne, Australia. | Investitore di Private Equity | 01/01/2015 |
Precedenti posizioni note di Natalie McNamee
| Società | Posizione | Fine |
|---|---|---|
| JUPITER NEUROSCIENCES, INC. | Direttore/Membro del Consiglio | - |
Formazione di Natalie McNamee
| University of California San Diego | Graduate Degree |
| University of Melbourne | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Jupiter Neurosciences, Inc.
 Jupiter Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Jupiter Neurosciences, Inc. is a clinical stage research and development pharmaceutical company. Its therapeutic candidate, JOTROL is applicable to many central nervous system diseases, including Alzheimer’s disease and traumatic brain injury. The company was founded by Christer Rosén, Alexander Rosén, Claes Wahlestedt, Marshall Hayward, and Shaun P. Brothers in June 2015 and is headquartered in Jupiter, FL. | Health Technology |
Tarnagulla Ventures Pty Ltd.
Tarnagulla Ventures Pty Ltd. Investment ManagersFinance Tarnagulla Ventures Pty Ltd (Tarnagulla Ventures) is a venture capital firm founded in 2015. The firm is headquartered in Melbourne, Australia. | Finance |
- Borsa valori
- Insiders
- Natalie McNamee
